NovoCure Limited
NVCR
$15.23
$0.030.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.66M | -71.14M | -24.50M | -37.27M | -40.14M |
| Total Depreciation and Amortization | 4.31M | 4.12M | 2.70M | 3.66M | 3.44M |
| Total Amortization of Deferred Charges | -- | -- | 5.15M | -- | -- |
| Total Other Non-Cash Items | 15.28M | 61.36M | 13.93M | 24.83M | 27.40M |
| Change in Net Operating Assets | 4.21M | -7.87M | -15.28M | 29.35M | -6.64M |
| Cash from Operations | 8.13M | -13.52M | -18.00M | 20.57M | -15.94M |
| Capital Expenditure | -6.92M | -5.15M | -4.90M | -5.66M | -5.49M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 538.00K | 12.90M | 341.22M | 77.09M | 41.47M |
| Cash from Investing | -6.38M | 7.75M | 336.33M | 71.44M | 35.99M |
| Total Debt Issued | -- | -- | 0.00 | 99.98M | -- |
| Total Debt Repaid | -- | -- | -560.95M | -- | -- |
| Issuance of Common Stock | 4.55M | 390.00K | 1.60M | 538.00K | 2.39M |
| Repurchase of Common Stock | -- | -556.00K | -146.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.55M | -166.00K | -559.49M | 100.52M | 2.39M |
| Foreign Exchange rate Adjustments | -8.00K | -130.00K | -76.00K | -22.00K | 265.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.29M | -6.07M | -241.25M | 192.51M | 22.70M |